002261:SZSETalkweb Information System Co.,Ltd. Analysis
Data as of 2026-03-07 - not real-time
CN¥39.05
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Talkweb’s share price is riding strong technical momentum, staying above its short‑term averages and breaking recent highs with a bullish MACD crossover and an RSI that signals overbought conditions. Volume has been rising, beta is exceptionally low and the stock is trading near a key resistance level, suggesting short‑term upside potential.
Fundamentally the company is under pressure: revenue is contracting, margins are thin and profitability is negative, while the forward price‑to‑earnings multiple dwarfs the industry average and the discounted cash‑flow valuation is far below the current market price. The firm carries a modest debt load relative to cash, but equity returns are negative and there is no dividend, raising concerns about long‑term value creation.
Fundamentally the company is under pressure: revenue is contracting, margins are thin and profitability is negative, while the forward price‑to‑earnings multiple dwarfs the industry average and the discounted cash‑flow valuation is far below the current market price. The firm carries a modest debt load relative to cash, but equity returns are negative and there is no dividend, raising concerns about long‑term value creation.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- Bullish technical indicators approaching resistance
- Elevated valuation relative to fundamentals
- Increasing trading volume supporting price momentum
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Weak earnings and margin compression
- High forward PE versus industry peers
- Strong cash position but limited growth outlook
Long Term
> 3 yearsCautious
Model confidence: 4/10
Key Factors
- Persistent revenue decline and negative profitability
- Valuation far above discounted cash‑flow estimate
- Regulatory headwinds in education and digital services
Key Metrics & Analysis
Financial Health
Revenue Growth-36.50%
Profit Margin-0.21%
P/E Ratio205.5
ROE-0.86%
ROA-0.50%
Debt/Equity15.09
P/B Ratio18.9
Op. Cash FlowCN¥1.4B
Free Cash FlowCN¥1.2B
Industry P/E36.2
Technical Analysis
TrendBullish
RSI68.2
SupportCN¥30.28
ResistanceCN¥39.05
MA 20CN¥33.37
MA 50CN¥33.16
MA 200CN¥33.08
MACDBullish
VolumeIncreasing
Fear & Greed Index68.77
Valuation
Fair ValueCN¥14.25
Target PriceCN¥0.00
GradeOvervalued
TypeValue
Risk Assessment
Beta0.10
Volatility51.39%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.